Droplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify ...

Real Chemistry, a 2024 MM+M Agency 100 honoree, appointed Cali Howitt, PhD, as president of U.S. medical and executive leader for its promotional and medical affairs business in the U.S. General ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

"The quantity of ctDNA detected was important," Polsky told MedPage Today. "The higher the level of ctDNA, the greater the ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...

The Swiss pharmaceutical company Novartis has announced significant investments in the US, days after President Donald Trump threatened to impose tariffs on foreign drugs. The company announced that ...

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...